PROM and PREM preferences in COPD-patients
I. Gyselinck (Leuven, Belgium), K. Vermeersch (Leuven, Belgium), H. Pott (Marburg, Germany), S. Ramakrishnan (Oxford, United Kingdom), A. Halner (Oxford, United Kingdom), P. Collis (Birmingham, United Kingdom), C. Coleman (Sheffield, United Kingdom), H. Watz (Grosshansdorf, Germany), F. Dobbels (Leuven, Belgium), F. Franssen (Maastricht, Netherlands), T. Greulich (Marburg, Germany), P. Burgel (Paris, France), M. Bafadhel (Oxford, United Kingdom), W. Janssens (Leuven, Belgium)
Source: International Congress 2022 – COPD: from biomarkers to phenotypes and severity
Session: COPD: from biomarkers to phenotypes and severity
Session type: Thematic Poster
Number: 3886
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Gyselinck (Leuven, Belgium), K. Vermeersch (Leuven, Belgium), H. Pott (Marburg, Germany), S. Ramakrishnan (Oxford, United Kingdom), A. Halner (Oxford, United Kingdom), P. Collis (Birmingham, United Kingdom), C. Coleman (Sheffield, United Kingdom), H. Watz (Grosshansdorf, Germany), F. Dobbels (Leuven, Belgium), F. Franssen (Maastricht, Netherlands), T. Greulich (Marburg, Germany), P. Burgel (Paris, France), M. Bafadhel (Oxford, United Kingdom), W. Janssens (Leuven, Belgium). PROM and PREM preferences in COPD-patients. 3886
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|